Literature DB >> 21559999

Review of the pathogenesis, diagnosis, and management of type I gastric carcinoid tumor.

Linda Zhang1, Junko Ozao, Richard Warner, Celia Divino.   

Abstract

Gastric carcinoid tumors comprise 7% of all gastrointestinal carcinoids and have significantly increased in incidence over the past few decades. Seventy to 80% of gastric carcinoids are type I, which usually are clinically asymptomatic and found incidentally at endoscopic evaluation for abdominal pain or anemia. In this review, advances in understanding the pathophysiology of type I gastric carcinoid are highlighted. In addition, various current diagnostic and treatment options are discussed. Although type I carcinoids generally hold a benign course, rigorous investigation is needed to ensure accurate diagnosis and optimal treatment. This includes appropriate diagnostic procedures and imaging and accurate staging of tumor. Tumor size, depth of invasion, presence of metastasis, and the tumor's gastrin dependency dictate treatment options. Appropriate treatments can consist of endoscopic resection, antrectomy, medical management, or frequent follow-up. This article provides a systematic method of evaluating and treating type I gastric carcinoid.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21559999     DOI: 10.1007/s00268-011-1137-0

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  46 in total

Review 1.  EUS in submucosal tumors.

Authors:  Amitabh Chak
Journal:  Gastrointest Endosc       Date:  2002-10       Impact factor: 9.427

2.  Treatment of gastric neuroendocrine tumors: the necessity of a type-adapted treatment.

Authors:  M Schindl; K Kaserer; B Niederle
Journal:  Arch Surg       Date:  2001-01

3.  Endoscopic mucosal resection in the management of gastric carcinoid tumors.

Authors:  J Ichikawa; S Tanabe; W Koizumi; Y Kida; H Imaizumi; M Kida; K Saigenji; H Mitomi
Journal:  Endoscopy       Date:  2003-03       Impact factor: 10.093

Review 4.  [Gastric carcinoid tumours. Is there a place for antrectomy?].

Authors:  P Guillem
Journal:  Ann Chir       Date:  2005-04-13

5.  Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases.

Authors:  C Bordi; J Y Yu; M T Baggi; C Davoli; F P Pilato; G Baruzzi; G Gardini; G Zamboni; G Franzin; M Papotti
Journal:  Cancer       Date:  1991-02-01       Impact factor: 6.860

6.  Ability of somatostatin receptor scintigraphy to identify patients with gastric carcinoids: a prospective study.

Authors:  F Gibril; J C Reynolds; I A Lubensky; P K Roy; P L Peghini; J L Doppman; R T Jensen
Journal:  J Nucl Med       Date:  2000-10       Impact factor: 10.057

Review 7.  Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion.

Authors:  C J Gilligan; G P Lawton; L H Tang; A B West; I M Modlin
Journal:  Am J Gastroenterol       Date:  1995-03       Impact factor: 10.864

8.  Gastric polypoid lesions: analysis of 150 endoscopic polypectomy specimens from 91 patients.

Authors:  Rasim Gencosmanoglu; Ebru Sen-Oran; Ozlem Kurtkaya-Yapicier; Erol Avsar; Aydin Sav; Nurdan Tozun
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

Review 9.  Neuroendocrine gastrointestinal tumours.

Authors:  K Oberg
Journal:  Ann Oncol       Date:  1996-07       Impact factor: 32.976

10.  Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs.

Authors:  D Campana; F Nori; R Pezzilli; L Piscitelli; D Santini; E Brocchi; R Corinaldesi; P Tomassetti
Journal:  Endocr Relat Cancer       Date:  2008-03       Impact factor: 5.678

View more
  11 in total

Review 1.  Endoscopic diagnosis and management of type I neuroendocrine tumors.

Authors:  Yuichi Sato
Journal:  World J Gastrointest Endosc       Date:  2015-04-16

Review 2.  Clinical features and management of type I gastric carcinoids.

Authors:  Yuichi Sato
Journal:  Clin J Gastroenterol       Date:  2014-09-17

Review 3.  Management of gastric and duodenal neuroendocrine tumors.

Authors:  Yuichi Sato; Satoru Hashimoto; Ken-Ichi Mizuno; Manabu Takeuchi; Shuji Terai
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

4.  A case of neuroendocrine tumor G1 with unique histopathological growth progress.

Authors:  Misuzu Hirai; Kenshi Matsumoto; Hiroya Ueyama; Hirohumi Fukushima; Takashi Murakami; Hitoshi Sasaki; Akihito Nagahara; Takashi Yao; Sumio Watanabe
Journal:  World J Gastrointest Endosc       Date:  2013-12-16

5.  Recurrent gastric neuroendocrine tumors treated with total gastrectomy.

Authors:  Myounghwa Jung; Jung-Wook Kim; Jae-Young Jang; Young Woon Chang; Sun Hee Park; Yong Ho Kim; Youn Wha Kim
Journal:  World J Gastroenterol       Date:  2015-12-14       Impact factor: 5.742

6.  Surgical Intervention in Gastric Carcinoid is Associated With Improved Survival in Local and Regional Disease.

Authors:  Ann F Callahan; Michael White; Philip Ituarte; Singh Gagandeep; Yanghee Woo; Yuman Fong; Laleh Melstrom
Journal:  Am J Clin Oncol       Date:  2018-09       Impact factor: 2.339

7.  A knockin mouse model for human ATP4aR703C mutation identified in familial gastric neuroendocrine tumors recapitulates the premalignant condition of the human disease and suggests new therapeutic strategies.

Authors:  Oriol Calvete; Andrea Varro; D Mark Pritchard; Alicia Barroso; Marta Oteo; Miguel Ángel Morcillo; Pierfrancesco Vargiu; Steven Dodd; Miriam Garcia; José Reyes; Sagrario Ortega; Javier Benitez
Journal:  Dis Model Mech       Date:  2016-08-04       Impact factor: 5.758

8.  Current concepts on gastric carcinoid tumors.

Authors:  George C Nikou; Theodoros P Angelopoulos
Journal:  Gastroenterol Res Pract       Date:  2012-12-17       Impact factor: 2.260

Review 9.  Endoscopic treatment for early foregut neuroendocrine tumors.

Authors:  Moo In Park
Journal:  Clin Endosc       Date:  2013-09-30

10.  The efficacy of endoscopic submucosal dissection of type I gastric carcinoid tumors compared with conventional endoscopic mucosal resection.

Authors:  Hyung Hun Kim; Gwang Ha Kim; Ji Hyun Kim; Myung-Gyu Choi; Geun Am Song; Sung Eun Kim
Journal:  Gastroenterol Res Pract       Date:  2014-02-17       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.